Yayın:
Neurometabolic correlations of donepezil and rivastigmine in dementia patients: A different neuroprotective effect

Basit Görünüm
dc.contributor.authorYuluğ, Burak
dc.contributor.buuauthorParlayan, Ebru
dc.contributor.buuauthorBakar, Mustafa
dc.contributor.buuauthorGümüştaş, Oğuzhan Güven
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentNöroloji Ana Bilim Dalı
dc.contributor.departmentRadyoloji Ana Bilim Dalı
dc.contributor.scopusid40262210100
dc.contributor.scopusid26643051200
dc.contributor.scopusid9237715700
dc.date.accessioned2022-03-08T10:52:15Z
dc.date.available2022-03-08T10:52:15Z
dc.date.issued2009
dc.identifier.citationParlayan, E. vd. (2009). "Neurometabolic correlations of donepezil and rivastigmine in dementia patients: A different neuroprotective effect". Journal of Neuropsychiatry and Clinical Neurosciences, 21(3), 348-350.
dc.identifier.doi10.1176/jnp.2009.21.3.348
dc.identifier.endpage350
dc.identifier.issn0895-0172
dc.identifier.issue3
dc.identifier.pubmed19776323
dc.identifier.scopus2-s2.0-70349633251
dc.identifier.startpage348
dc.identifier.urihttps://doi.org/10.1176/jnp.2009.21.3.348
dc.identifier.urihttps://neuro.psychiatryonline.org/doi/full/10.1176/jnp.2009.21.3.348
dc.identifier.urihttp://hdl.handle.net/11452/24909
dc.identifier.volume21
dc.identifier.wos000270098900023
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherAmer Psychiatric Publishing
dc.relation.collaborationSanayi
dc.relation.journalJournal of Neuropsychiatry and Clinical Neurosciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectNeurosciences & neurology
dc.subjectPsychiatry
dc.subject.emtreeCholine esterase inhibitor
dc.subject.emtreeDonepezil
dc.subject.emtreeNeuroprotective agent
dc.subject.emtreeRivastigmine
dc.subject.emtreeUnclassified drug
dc.subject.emtreeAlzheimer disease
dc.subject.emtreeCognition
dc.subject.emtreeComputer assisted tomography
dc.subject.emtreeDementia
dc.subject.emtreeEnzyme inhibition
dc.subject.emtreeHuman
dc.subject.emtreeLetter
dc.subject.emtreeNeuroprotection
dc.subject.emtreeNuclear magnetic resonance imaging
dc.subject.emtreeNuclear magnetic resonance spectroscopy
dc.subject.emtreePriority journal
dc.subject.meshAged
dc.subject.meshAspartic acid
dc.subject.meshBrain
dc.subject.meshCognition disorders
dc.subject.meshDementia
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshIndans
dc.subject.meshMagnetic resonance spectroscopy
dc.subject.meshMale
dc.subject.meshMiddle aged
dc.subject.meshNeuroprotective agents
dc.subject.meshNeuropsychological tests
dc.subject.meshPhenylcarbamates
dc.subject.meshPiperidines
dc.subject.meshPsychiatric status rating scales
dc.subject.meshTreatment outcome
dc.subject.scopusCreatine; N Acetylaspartic Acid; Cognitive Dysfunction
dc.subject.wosClinical neurology
dc.subject.wosNeurosciences
dc.subject.wosPsychiatry
dc.titleNeurometabolic correlations of donepezil and rivastigmine in dementia patients: A different neuroprotective effect
dc.typeLetter
dc.wos.quartileQ2
dc.wos.quartileQ3 (Neurosciences)
dc.wos.quartileQ2
dc.wos.quartileQ3
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Nöroloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Radyoloji Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama
İndir

Koleksiyonlar

İndeksli Yayınlar / Indexed Publications